Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
Momordica charantia, commonly called bitter melon, is a plant belonging to Cucurbitaceae
family known for centuries for its pharmacological activities, and nutritional properties. Due …
family known for centuries for its pharmacological activities, and nutritional properties. Due …
Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy
Recently, there is a paradigm shift that the whole food-derived components are not 'idle
bystanders' but actively participate in modulating aberrant metabolic and signaling pathways …
bystanders' but actively participate in modulating aberrant metabolic and signaling pathways …
A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia
SF Oyelere, OH Ajayi, TE Ayoade, GBS Pereira… - Heliyon, 2022 - cell.com
Diabetes mellitus is the most well-known endocrine dilemma suffered by hundreds of million
people globally, with an annual mortality of more than one million people. This high mortality …
people globally, with an annual mortality of more than one million people. This high mortality …
Triterpenoids
RA Hill, JD Connolly - Natural Product Reports, 2020 - pubs.rsc.org
Covering 2015. Previous review: Nat. Prod. Rep., 2018, 35, 1294–1329 This review covers
the isolation and structure determination of triterpenoids reported during 2015 including …
the isolation and structure determination of triterpenoids reported during 2015 including …
The triterpenoids of the bitter gourd (Momordica Charantia) and their pharmacological activities: A review
L Sun, X Zhang, L Dong, C Zhang, P Guo… - Journal of Food …, 2021 - Elsevier
The bitter gourd (Momordica charantia L.) is a world-famous medical vegetable involved in
multiple pharmacological activities especially known for its lipid-and glucose-lowering …
multiple pharmacological activities especially known for its lipid-and glucose-lowering …
Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches
Momordica charantia L., commonly known as bitter melon, belongs to the Cucurbitaceae
family. Various in vitro and in vivo studies have indicated that extracts of bitter melons have …
family. Various in vitro and in vivo studies have indicated that extracts of bitter melons have …
Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of Momordica charantia …
Diabetes mellitus is a chronic disease and one of the fastest-growing health challenges of
the last decades. Studies have shown that chronic low-grade inflammation and activation of …
the last decades. Studies have shown that chronic low-grade inflammation and activation of …
Phytochemical profile and biological activities of Momordica charantia L.(Cucurbitaceae): A review
MS de Oliveira, WA da Costa… - African Journal of …, 2018 - academicjournals.org
This study discusses the bioactive composition, supercritical fluid extraction and biological
activities of Momordica charantia L. from the last five years. Numerous compounds that have …
activities of Momordica charantia L. from the last five years. Numerous compounds that have …
In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.
Bitter melon (Momordica charantia) has been used to manage diabetes and related
conditions in various parts of the world. In the present study, ten compounds were isolated …
conditions in various parts of the world. In the present study, ten compounds were isolated …
A triterpenoid from wild bitter gourd inhibits breast cancer cells
The antitumor activity of 3β, 7β, 25-trihydroxycucurbita-5, 23 (E)-dien-19-al (TCD), a
triterpenoid isolated from wild bitter gourd, in breast cancer cells was investigated. TCD …
triterpenoid isolated from wild bitter gourd, in breast cancer cells was investigated. TCD …